Non-Executive Director
LPP Investments
Chair of the LPP Investments Audit and Risk Committee
Robert Vandersluis is the Director of Global Pension Investments at GlaxoSmithKline (GSK), where he manages £20 billion of investments and a substantial derivative portfolio. At GSK, Robert sits on a number of pension boards, and he provides strategic advice to GSK’s pension fund trustees in Europe, the United States and Japan. Robert established GSK’s London-based pension investment department, where he developed and implemented GSK’s interest rate and inflation hedging strategies.
Robert’s previous roles include senior treasury and corporate finance positions at Affinity Sutton Group and FCE Bank plc. He also served on the board of the Pensions Trust, where he
was Deputy Chair of the Investment Committee.
Robert studied economics and public policy at the London School of Economics, the University of Michigan, Cambridge University, and Harvard University’s Kennedy School of Government.
Robert Vandersluis is the Director of Global Pension Investments at GlaxoSmithKline (GSK), where he manages £20 billion of investments and a substantial derivative portfolio. At GSK, Robert sits on a number of pension boards, and he provides strategic advice to GSK’s pension fund trustees in Europe, the United States and Japan. Robert established GSK’s London-based pension investment department, where he developed and implemented GSK’s interest rate and inflation hedging strategies.
Robert’s previous roles include senior treasury and corporate finance positions at Affinity Sutton Group and FCE Bank plc. He also served on the board of the Pensions Trust, where he was Deputy Chair of the Investment Committee.
Robert studied economics and public policy at the London School of Economics, the University of Michigan, Cambridge University, and Harvard University’s Kennedy School of Government.